Skip to content

The effects of hyperbaric oxygen therapy on treatment of chronic prostatitis: randomized controlled preliminary study

The effects of hyperbaric oxygen therapy on treatment of chronic prostatitis/chronic pelvic pain syndrome (NIH type III): single blind randomized controlled preliminary study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007108
Enrollment
24
Registered
2022-03-23
Start date
2022-04-01
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : See below.

Sponsors

Yonsei University, Wonju Severance Christian Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Men 19 to 60 years old with a history of pain or discomfort perceived in the prostate region with no other lower urinary tract pathology for a minimum of 3 of the last 6 months 2) National Institutes of Health Chronic Prostatitis Symptom Index total score greater than 15 3) Ability to understand and the willingness to sign a written informed consent

Exclusion criteria

Exclusion criteria: 1) History of other lower urinary tract pathology such as urinary tract cancer, urinary tract infection including acute prostatitis, neurogenic bladder, and surgery 2) Contraindication of hyperbaric oxygen therapy such as pneumothorax, cardiovascular surgery, chronic pulmonary obstructive disease, upper respiratory infection, fever, and cancer 3) Participants who were diagnosed as infectious or inflammatory disease, and musculoskeletal disease within recent 3 months 4) Men with female spouses who are pregnant, breastfeeding or refuse contraception

Design outcomes

Primary

MeasureTime frame
National Institutes of Health Chronic Prostatitis Symptom Index;Adverse event due to hyperbaric oxygen therapy

Secondary

MeasureTime frame
International Prostate Symptom Score;International Erectile Function Index-5;Maximum flow rate;Postvoid residual urine

Countries

Korea, Republic of

Contacts

Public ContactJae Hung Jung

Yonsei University Wonju College of Medicine

geneuro95@yonsei.ac.kr+82-33-741-0652

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026